ZA881791B - Therapeutic compositions - Google Patents
Therapeutic compositionsInfo
- Publication number
- ZA881791B ZA881791B ZA881791A ZA881791A ZA881791B ZA 881791 B ZA881791 B ZA 881791B ZA 881791 A ZA881791 A ZA 881791A ZA 881791 A ZA881791 A ZA 881791A ZA 881791 B ZA881791 B ZA 881791B
- Authority
- ZA
- South Africa
- Prior art keywords
- therapeutic compositions
- therapeutic
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/22—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB878706052A GB8706052D0 (en) | 1987-03-13 | 1987-03-13 | Therapeutic compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA881791B true ZA881791B (en) | 1989-01-25 |
Family
ID=10613927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA881791A ZA881791B (en) | 1987-03-13 | 1988-03-14 | Therapeutic compositions |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0287210A3 (de) |
AU (1) | AU1308988A (de) |
GB (1) | GB8706052D0 (de) |
IL (1) | IL85719A0 (de) |
ZA (1) | ZA881791B (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5200179A (en) * | 1987-09-28 | 1993-04-06 | Beecham Group P.L.C. | Vaccine |
CA1340994C (en) * | 1989-09-21 | 2000-05-16 | Rudolf Edgar Dr. Falk | Treatment of conditions and disease |
US5639738A (en) * | 1992-02-20 | 1997-06-17 | Hyal Pharmaceutical Corporation | Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs |
GB2252729B (en) * | 1991-02-13 | 1994-11-09 | Bharat Sridhar Pancham | Vitamin and/or mineral containing pharmaceutical compositions |
US6103704A (en) * | 1991-07-03 | 2000-08-15 | Hyal Pharmaceutical Corporation | Therapeutic methods using hyaluronic acid |
US5817644A (en) * | 1991-07-03 | 1998-10-06 | Hyal Pharmaceutical Corporation | Targeting of dosages of medicine and therapeutic agents |
US6022866A (en) * | 1991-07-03 | 2000-02-08 | Hyal Pharmaceutical Corporation | Use of hyaluronic acid and forms to prevent arterial restenosis |
WO1994007505A1 (en) * | 1991-07-03 | 1994-04-14 | Norpharmco Inc. | Use of hyaluronic acid and forms to prevent arterial restenosis |
US5990095A (en) * | 1991-07-03 | 1999-11-23 | Hyal Pharmaceutical Corporation | Use of hyaluronic acid and forms to prevent arterial restenosis |
US5792753A (en) * | 1991-07-03 | 1998-08-11 | Hyal Pharmaceutical Corporation | Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs |
CA2061567C (en) * | 1992-02-20 | 1998-02-03 | Rudolf E. Falk | Use of hyaluronic acid to repair ischemia reperfusion damage |
US6136793A (en) * | 1992-02-20 | 2000-10-24 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
US6114314A (en) * | 1992-02-21 | 2000-09-05 | Hyal Pharmaceutical Corp. | Formulations containing hyaluronic acid |
FR2715301A1 (fr) * | 1994-01-24 | 1995-07-28 | Aromafarm Ltd | Application d'au moins un sel métallique de l'acide ascorbique comme antiviral administrable par voie générale et composition pharmaceutique. |
DE4441483C1 (de) * | 1994-11-22 | 1996-04-04 | Gsf Forschungszentrum Umwelt | Verwendung von bio-assimilierbaren Borverbindungen |
GB9521454D0 (en) * | 1995-10-19 | 1995-12-20 | Kappa Pharmaceuticals Ltd | Compositions for the treatment of conditions caused by herpes virus |
AU2003900064A0 (en) * | 2003-01-09 | 2003-01-23 | Penam Investments Pty. Ltd. | A method of treatment or prophylaxis of viral infection. |
ITRM20030394A1 (it) * | 2003-08-12 | 2005-02-13 | Maria Gabriella Santoro | Uso dell'indometacina e derivati come farmaci antivirali e relative composizioni farmaceutiche. |
AU2007295894B2 (en) | 2006-09-13 | 2013-10-17 | Enhance Skin Products, Inc. | Cosmetic composition for the treatment of skin and methods thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5946223A (ja) * | 1982-08-30 | 1984-03-15 | Daito Koeki Kk | 抗菌性組成物 |
GB8320203D0 (en) * | 1983-07-27 | 1983-09-01 | Horrobin D F | Anti-viral compositions |
GB8320308D0 (en) * | 1983-07-28 | 1983-09-01 | Wellcome Found | Antiviral combinations |
-
1987
- 1987-03-13 GB GB878706052A patent/GB8706052D0/en active Pending
-
1988
- 1988-03-11 EP EP88302146A patent/EP0287210A3/de not_active Withdrawn
- 1988-03-13 IL IL85719A patent/IL85719A0/xx unknown
- 1988-03-14 ZA ZA881791A patent/ZA881791B/xx unknown
- 1988-03-14 AU AU13089/88A patent/AU1308988A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0287210A3 (de) | 1990-03-28 |
EP0287210A2 (de) | 1988-10-19 |
IL85719A0 (en) | 1988-08-31 |
GB8706052D0 (en) | 1987-04-15 |
AU1308988A (en) | 1988-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0293885A3 (en) | Antibiotic-polymer compositions | |
GB8710965D0 (en) | Pharmaceutical compositions | |
GB8827331D0 (en) | Compositions | |
ZA881791B (en) | Therapeutic compositions | |
EG18652A (en) | Pharmaceutical compositions | |
GB8606468D0 (en) | Therapeutic compositions | |
NZ224363A (en) | Ophthalmological compositions | |
GB8702613D0 (en) | Compositions | |
GB8508404D0 (en) | Therapeutic compositions | |
GB8713091D0 (en) | Pharmaceutical compositions | |
GB8716338D0 (en) | Anti-anxiogenic compositions | |
GB8700466D0 (en) | Teat-treating compositions | |
IE870643L (en) | Selant compositions | |
GB8710656D0 (en) | Therapeutic composition | |
ZA874324B (en) | Therapeutic compositions | |
GB8616931D0 (en) | Therapeutic compositions | |
GB8908847D0 (en) | Therapeutic compositions | |
GB9008780D0 (en) | Therapeutic compositions | |
IE870402L (en) | Antiviral-antitumor compositions | |
GB8703752D0 (en) | Compositions | |
GB8728784D0 (en) | Compositions | |
GB8728785D0 (en) | Compositions | |
GB8713945D0 (en) | Compositions | |
GB8713513D0 (en) | Fibre-polymer compositions | |
GB8728783D0 (en) | Compositions |